Retraction: SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma (PLoS One (2013) 8:1 (e52184) DOI: 10.1371/journal.pone.0052184);SDR9C7 Promotes Lymph Node Metastases in Patients with Esophageal Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Tang, Shanhong ^a   Gao, Liucun ^a   Bi, Qian ^a   Xu, Guanghui ^a   Wang, Simeng ^a   Zhao, Guohong ^a   Chen, Zheng ^a   Zheng, Xiushan ^a   Pan, Yanglin ^a   Zhao, Lina ^a   Kang, Jianqin ^a   Yang, Guitao ^a   Shi, Yongquan ^a   Wu, Kaichun ^a   Gong, Taiqian ^a,b   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

STROMELYSIN 3;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INVASION; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MMP11 GENE; MOUSE; NONHUMAN; OBSERVATIONAL STUDY; PROTEIN PROTEIN INTERACTION; SDR9C7 GENE; TUMOR GENE; UPREGULATION; WESTERN BLOTTING;

EID: 84872310524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0227461     Document Type: Erratum

References (22)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Rice TW, Zuccaro G Jr, Adelstein DJ, Rybicki LA, Blackstone EH, et al. (1998) Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 65: 787-792.
3. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM, (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95: 1434-1443.
4. Jin H, Morohashi S, Sato F, Kudo Y, Akasaka H, et al. (2010) Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res 31: 105-112.
5. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Ehi K, et al. (2009) Vascular endothelial growth factor-C and-D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. J Surg Oncol 99: 148-153.
6. SSAT patient care guidelines. Surgical treatment of esophageal cancer. J Gastrointest Surg 11: 1216-1218.
7. Gong T, Xue Z, Tang S, Zheng X, Xu G, et al. (2012) Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma. Cancer Biol Ther 13: 606-613.
8. Nguyen ST, Hasegawa S, Tsuda H, Tomioka H, Ushijima M, et al. (2007) Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci 98: 740-746.
9. Moriya Y, Iyoda A, Kasai Y, Sugimoto T, Hashida J, et al. (2009) Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer. Lung Cancer 64: 86-91.
10. Kim TJ, Choi JJ, Kim WY, Choi CH, Lee JW, et al. (2008) Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer. Cancer Sci 99: 31-38.
11. Lagarde SM, Ver Loren van Themaat PE, Moerland PD, Gilhuijs-Pederson LA, Ten Kate FJ, et al. (2008) Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus. Ann Surg Oncol 15: 3459-3470.
12. Kita Y, Mimori K, Iwatsuki M, Yokobori T, Ieta K, et al. (2011) STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma. Ann Surg Oncol 18: 261-272.
13. Tang S, Yang G, Meng Y, Du R, Li X, et al. (2010) Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther 9: 88-95.
14. Huang D, Gao Q, Guo L, Zhang C, Jiang W, et al. (2009) Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 18: 465-473.
15. Tie J, Pan Y, Zhao L, Wu K, Liu J, et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879.
16. Liang S, He L, Zhao X, Miao Y, Gu Y, et al. (2011) MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 6: e18409.
17. Chen W, Song MS, Napoli JL, (2002) SDR-O: an orphan short-chain dehydrogenase/reductase localized at mouse chromosome 10/human chromosome 12. Gene 294: 141-146.
18. Kallberg Y, Persson B, (2006) Prediction of coenzyme specificity in dehydrogenases/reductases. A hidden Markov model-based method and its application on complete genomes. FEBS J 273: 1177-1184.
19. Bray JE, Marsden BD, Oppermann U, (2009) The human short-chain dehydrogenase/reductase (SDR) superfamily: a bioinformatics summary. Chem Biol Interact 178: 99-109.
20. Hoffmann F, Maser E, (2007) Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily. Drug Metab Rev 39: 87-144.
21. Oppermann UC, Filling C, Jornvall H, (2001) Forms and functions of human SDR enzymes. Chem Biol Interact 130-132: 699-705.
22. Huang C, Wan B, Gao B, Hexige S, Yu L, (2009) Isolation and characterization of novel human short-chain dehydrogenase/reductase SCDR10B which is highly expressed in the brain and acts as hydroxysteroid dehydrogenase. Acta Biochim Pol 56: 279-289.